Literature DB >> 24338365

The human CFTR protein expressed in CHO cells activates aquaporin-3 in a cAMP-dependent pathway: study by digital holographic microscopy.

Pascal Jourdain1, Frédéric Becq, Sylvain Lengacher, Clément Boinot, Pierre J Magistretti, Pierre Marquet.   

Abstract

The transmembrane water movements during cellular processes and their relationship to ionic channel activity remain largely unknown. As an example, in epithelial cells it was proposed that the movement of water could be directly linked to cystic fibrosis transmembrane conductance regulator (CFTR) protein activity through a cAMP-stimulated aqueous pore, or be dependent on aquaporin. Here, we used digital holographic microscopy (DHM) an interferometric technique to quantify in situ the transmembrane water fluxes during the activity of the epithelial chloride channel, CFTR, measured by patch-clamp and iodide efflux techniques. We showed that the water transport measured by DHM is fully inhibited by the selective CFTR blocker CFTRinh172 and is absent in cells lacking CFTR. Of note, in cells expressing the mutated version of CFTR (F508del-CFTR), which mimics the most common genetic alteration encountered in cystic fibrosis, we also show that the water movement is profoundly altered but restored by pharmacological manipulation of F508del-CFTR-defective trafficking. Importantly, whereas activation of this endogenous water channel required a cAMP-dependent stimulation of CFTR, activation of CFTR or F508del-CFTR by two cAMP-independent CFTR activators, genistein and MPB91, failed to trigger water movements. Finally, using a specific small-interfering RNA against the endogenous aquaporin AQP3, the water transport accompanying CFTR activity decreased. We conclude that water fluxes accompanying CFTR activity are linked to AQP3 but not to a cAMP-stimulated aqueous pore in the CFTR protein.

Entities:  

Keywords:  Aquaporin AQP3; CFTR protein; Digital holographic microscopy; F508del-CFTR; Water transport; cAMP pathway

Mesh:

Substances:

Year:  2013        PMID: 24338365     DOI: 10.1242/jcs.133629

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  6 in total

Review 1.  Review of quantitative phase-digital holographic microscopy: promising novel imaging technique to resolve neuronal network activity and identify cellular biomarkers of psychiatric disorders.

Authors:  Pierre Marquet; Christian Depeursinge; Pierre J Magistretti
Journal:  Neurophotonics       Date:  2014-09-22       Impact factor: 3.593

2.  A physiologically-motivated model of cystic fibrosis liquid and solute transport dynamics across primary human nasal epithelia.

Authors:  Florencio Serrano Castillo; Carol A Bertrand; Michael M Myerburg; Monica E Shapiro; Timothy E Corcoran; Robert S Parker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-09-07       Impact factor: 2.745

Review 3.  Hallmarks of therapeutic management of the cystic fibrosis functional landscape.

Authors:  Margarida D Amaral; William E Balch
Journal:  J Cyst Fibros       Date:  2015-10-29       Impact factor: 5.482

4.  The Importance of Aquaporin 1 in Pancreatitis and Its Relation to the CFTR Cl- Channel.

Authors:  Viktória Venglovecz; Petra Pallagi; Lajos V Kemény; Anita Balázs; Zsolt Balla; Eszter Becskeházi; Eleonóra Gál; Emese Tóth; Ágnes Zvara; László G Puskás; Katalin Borka; Matthias Sendler; Markus M Lerch; Julia Mayerle; Jens-Peter Kühn; Zoltán Rakonczay; Péter Hegyi
Journal:  Front Physiol       Date:  2018-07-12       Impact factor: 4.566

5.  Image-Based Marker-Free Screening of GABAA Agonists, Antagonists, and Modulators.

Authors:  Benjamin Rappaz; Pascal Jourdain; Damiano Banfi; Fabien Kuttler; Pierre Marquet; Gerardo Turcatti
Journal:  SLAS Discov       Date:  2019-11-28       Impact factor: 3.341

Review 6.  Neurodegeneration and Neuro-Regeneration-Alzheimer's Disease and Stem Cell Therapy.

Authors:  Verica Vasic; Kathrin Barth; Mirko H H Schmidt
Journal:  Int J Mol Sci       Date:  2019-08-31       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.